The FDA has been presented the robust evidence to support new primary wound care endpoints in clinical trials for approvals of new devices and drugs. This author details the new proposed endpoints and the collaborative approach that went into...
The FDA has been presented the robust evidence to support new primary wound care endpoints in clinical trials for approvals of new devices and drugs. This author details the new proposed endpoints and the collaborative approach that went into...
The FDA has been presented the...